Evaluation of efficacy of Kremezin in peripheral arterial disease patients with chronic kidney disease
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2019
Price : $35 *
At a glance
- Drugs Charcoal (Primary)
- Indications Kidney disorders; Peripheral arterial disorders
- Focus Therapeutic Use
- 03 Apr 2019 Status changed from active, no longer recruiting to completed.
- 03 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Jul 2016 Planned End Date changed from 31 Mar 2017 to 31 Mar 2018.